From: Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
Gender | HR | 95% CI | P | HR | 95% CI | P |
Male/female | 1.340 | 0.847-1.952 | 0.438 | |||
Age (years) | ||||||
<60/≥60 | 0.982 | 0.674-1.283 | 0.572 | |||
TNM stage | ||||||
I-II/III- IV | 2.542 | 1.734-5.863 | 0.002 | 1.84 | 1.546-2.874 | 0.056 |
Tumour size | ||||||
≤2 cm/>2 cm | 1.845 | 1.38-4.962 | 0.024 | 1.632 | 1.145-2.247 | 0.134 |
T classification | ||||||
T1-T2/T3-T4 | 1.472 | 0.863-2.168 | 0.386 | |||
N classification | ||||||
N0/N1 | 2.389 | 1.473-3.974 | 0.016 | 1.357 | 0.964-2.832 | 0.106 |
Histologic differentiation | ||||||
G1/G2-G3 | ||||||
Distant metastasis | ||||||
M0/M1 | 2.167 | 1.168-5.94 | 0.003 | 2.21 | 1.145-5.263 | 0.0239 |
Lymphatic invasion | ||||||
Yes/no | 1.149 | 0.793-2.865 | 0.067 | |||
Vascular invasion | ||||||
Yes/no | 1.354 | 0.872-2.004 | 0.138 | |||
Perineural invasion | ||||||
Yes/no | 1.457 | 0.641-2.359 | 0.275 | |||
Chemotherapy | ||||||
Yes/no | 1.580 | 0.794-2.356 | 0.192 | |||
XB130 expression | ||||||
Low/high | 2.396 | 1.273-3.944 | 0.0045 | 2.375 | 1.263-3.874 | 0.0043 |